Actualités

CENX posted a sharp Q2 profit increase as higher aluminum prices and shipments drove EBITDA to $326.9M, despite a sales miss.

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.

MIDD's Q2 earnings and sales beat estimates as Commercial Foodservice demand rose, while tariffs and inflation pressured margins.

With CPI dropping at 8:30 AM and the Strait of Hormuz near shutdown, Wall Street faces a pivotal morning that could swing stocks sharply in either direction, and analysts at Deutsche Bank, Oppenheimer, Berenberg, and others are already repositioning ahead of the numbers.

Record orders and raised guidance reflect strong data center and semiconductor demand.

DNOW's Q2 revenues surge 108% as earnings beat estimates, integration gains advanced and management raised its 2026 revenue and cash flow outlook.

Howmet Aerospace's Q2 earnings beat estimates as aerospace and gas turbine demand fuel 24% revenue growth and a higher 2026 outlook.

KMT's fiscal Q4 earnings and sales surge year over year, beating estimates as pricing, timing and broad end-market growth lift margins.

Does Idex (IEX) have what it takes to be a top stock pick for momentum investors? Let's find out.

EMR's Q3 earnings beat estimates as Software & Systems surged, margins expanded and strong cash flow supported a higher fiscal 2026 outlook.

POWL's fiscal Q3 earnings and revenues miss estimates, even as record orders and a $2.4 billion backlog strengthen its outlook.

Here is how Applied Industrial Technologies (AIT) and Idex (IEX) have performed compared to their sector so far this year.

RBC Bearings' fiscal first-quarter earnings and revenues top estimates as aerospace growth, VACCO and wider margins lift results.

IDEX (IEX) just released second quarter and first half 2026 results, along with an update on its long running share repurchase program, giving investors fresh numbers to evaluate the stock. See our latest analysis for IDEX. Recent earnings and buyback news come as IDEX trades at US$230.45, with the share price up 28.7% year to date and a 1 year total shareholder return of 46.98%. This points to momentum building over the past year despite a modest pullback in the last trading day. If you are...

IDEX Corporation recently reported its second-quarter 2026 results, with sales rising to US$920.6 million from US$865.4 million and diluted EPS from continuing operations increasing to US$1.93 from US$1.74 a year earlier. Alongside higher earnings, IDEX continued to shrink its share count, having repurchased about 25.04% of its stock for roughly US$1.74 billion since 2008, which can amplify per-share metrics over time. With IDEX lifting full-year organic growth and adjusted EPS guidance,...

Manufacturing company IDEX (NYSE:IEX) announced better-than-expected revenue in Q2 CY2026, with sales up 6.4% year on year to $920.6 million. Guidance for next quarter’s revenue was optimistic at $931.4 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $2.32 per share was 10.1% above analysts’ consensus estimates.

IDEX (NYSE:IEX) reported second-quarter 2026 results that exceeded its expectations, supported by growth in its Health & Science Technologies segment, stronger orders and operational execution. The company raised its full-year outlook for organic sales growth, adjusted EBITDA margin and adjusted

Moby summary of IDEX Corporation's Q2 2026 earnings call

IDEX Corp (IEX) reports robust Q2 performance with significant order growth and raises full-year financial outlook.

IEX tops second-quarter estimates, posts record orders above $1 billion and raises its 2026 outlook as demand improved across key end markets.

IDEX Corporation (NYSE:IEX) reported better-than-expected second-quarter earnings and revenue while raising its full-year guidance, sending the industrial technology company’s shares nearly 4% higher in premarket trading on Wednesday. Adjusted earnings came in at $2.

The headline numbers for Idex (IEX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Idex (IEX) delivered earnings and revenue surprises of +10.48% and +2.01%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Manufacturing company IDEX (NYSE:IEX) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 6.4% year on year to $920.6 million. Guidance for next quarter’s revenue was optimistic at $931.4 million at the midpoint, 2.1% above analysts’ estimates. Its non-GAAP profit of $2.32 per share was 10.1% above analysts’ consensus estimates.

Manufacturing company IDEX (NYSE:IEX) will be reporting results this Wednesday before market hours. Here’s what investors should know.

IEX reports Q2 results on July 29, with revenue growth expected as Health & Science demand and acquisitions support sales despite cost pressures.

IDEX has risen 24.7% year to date, yet its valuation signals are split, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while earnings based multiples lean the other way. The 24.7% year to date gain suggests investors have been willing to pay a richer price for IDEX shares in a relatively short period. The Discounted Cash Flow (DCF) intrinsic value estimate suggests the stock trades at about a 22.8% discount to projected cash flows, while market...

RBC Bearings (RBC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nvidia, Lam Research Lead Oppenheimer's Fresh Momentum Stock Picks